Founder and Chief Executive Officer
Greyledge operations are currently being led by company Founder and CEO – David Karli. He is responsible for all aspects of company development, including the integration of a strong team of professionals to support Greyledge’s innovative approach to regenerative medicine.
Vice President Research and Regulatory Affairs
Dr. Sand recently joined the company to support on-going commercialization efforts, as well as initiate an active research program to advance the company’s technology platform.
Director of Operations
Mark establishes and leads many of our logistics, quality, and supporting processes as Greyledge Technologies expands its’ services throughout the United States.